Showing results (61-70 of 156) with videos related to
Sort By:
Pageof 16
The Journal of Physical Chemistry Letters|August 13, 2024
La0.2Sr0.25Ca0.45TiO3 Surface Reactivity with H2: A Combined Operando NEXAFS and Computational StudyF Bassato, S Mauri, L Braglia, et al.Sarcoma|March 10, 2020
Analysis of the Chemotherapy-Free Interval following Image-Guided Ablation in Sarcoma PatientsCharles Sutton, Yachao Zhang, DaeHee Kim, et al.The American Journal of Surgical Pathology|November 15, 2022
Histopathologic Grading Is of Prognostic Significance in Primary Angiosarcoma of Breast: Proposal of a Simplified 2-tier Grading SystemMaria G Kuba, Josephine K Dermawan, Bin Xu, et al.Journal for Immunotherapy of Cancer|November 21, 2020
Efficacy and immune-related adverse event associations in avelumab-treated patientsKaren Kelly, Juliane Manitz, Manish R Patel, et al.Journal of Cardiac Surgery|July 4, 2019
Evaluation of a simulation-based mini-elective on medical student interest in cardiac surgeryGarrett N Coyan, Michael P D'Angelo, Arman Kilic, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutationsYelena Y Janjigian, Bernard J Park, Maureen F Zakowski, et al.The Annals of Thoracic Surgery|March 23, 2020
Predictors and Outcomes of Ischemic Stroke After Cardiac SurgeryIbrahim Sultan, Valentino Bianco, Arman Kilic, et al.Cancer|May 19, 2012
Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomasPaul K Paik, Melissa L Johnson, Sandra P D'Angelo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomasSandra P D'Angelo, M Catherine Pietanza, Melissa L Johnson, et al.JAMA Oncology|March 23, 2018
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical TrialSandra P D'Angelo, Jeffery Russell, Céleste Lebbé, et al.Pageof 16